All the news articles and press releases in one place.


Date / Time Source Company % Chg Sector Market Cap Announcement
07Jul20 11:13 RNS Evgen Pharma -4.29% Health £11.8m Share option exercise and issue of equity
06Jul20 07:00 RNS Evgen Pharma -4.29% Health £11.8m Share option exercise and issue of equity
23Jun20 11:44 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
23Jun20 11:38 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
19Jun20 07:00 RNS Evgen Pharma -4.29% Health £11.8m Notice of AGM
17Jun20 09:38 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
17Jun20 09:37 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
17Jun20 07:00 RNS Evgen Pharma -4.29% Health £11.8m SFX-01 to be evaluated in COVID-19 trial
15Jun20 17:05 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
15Jun20 07:00 RNS Evgen Pharma -4.29% Health £11.8m Final Results
08Jun20 07:00 RNS-R Evgen Pharma -4.29% Health £11.8m Paper on SFX-01 in ER positive breast cancer
05Jun20 07:00 RNS Evgen Pharma -4.29% Health £11.8m Notice of Results
15May20 12:30 RNS Evgen Pharma -4.29% Health £11.8m Statement Re: Share Price Movement
30Apr20 07:00 RNS Evgen Pharma -4.29% Health £11.8m Directorate Change
20Feb20 09:27 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
13Feb20 07:00 RNS Evgen Pharma -4.29% Health £11.8m University of Rochester Collaboration
06Feb20 07:00 RNS Evgen Pharma -4.29% Health £11.8m University of Manchester collaboration discovery
20Jan20 15:39 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
17Jan20 15:32 RNS Amati AIM VCT 0.00% Various Various Holding(s) in Company
08Jan20 09:52 RNS Amati AIM VCT 0.00% Various Various Holding(s) in Company
17Dec19 07:01 RNS-R Evgen Pharma -4.29% Health £11.8m Investor presentation
17Dec19 07:00 RNS Evgen Pharma -4.29% Health £11.8m Half-year Report
05Dec19 07:00 RNS Evgen Pharma -4.29% Health £11.8m MOU with The University of Dundee
04Dec19 15:11 RNS Evgen Pharma -4.29% Health £11.8m Notice of Results
14Nov19 11:59 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
11Nov19 12:11 RNS Evgen Pharma -4.29% Health £11.8m SAS study clarification
11Nov19 07:00 RNS Evgen Pharma -4.29% Health £11.8m SFX-01 results in SAS study
30Sep19 07:00 RNS Evgen Pharma -4.29% Health £11.8m ESMO presentation of Phase II STEM clinical data
23Sep19 07:00 RNS Evgen Pharma -4.29% Health £11.8m Update on extended-use phase of STEM trial
05Sep19 07:00 RNS Evgen Pharma -4.29% Health £11.8m Agreement for supply of SFX-01 for autism trial
28Aug19 07:00 RNS Evgen Pharma -4.29% Health £11.8m Update on SAS study
07Aug19 07:00 RNS Evgen Pharma -4.29% Health £11.8m Grant of further European patent
05Aug19 07:00 RNS-R Evgen Pharma -4.29% Health £11.8m Research collaboration
25Jul19 13:00 RNS Evgen Pharma -4.29% Health £11.8m Grant of Options
18Jul19 15:47 RNS Evgen Pharma -4.29% Health £11.8m Result of AGM
18Jul19 07:00 RNS Evgen Pharma -4.29% Health £11.8m AGM Statement
24Jun19 07:00 RNS-R Evgen Pharma -4.29% Health £11.8m SFX-01 featured in SAH review paper
19Jun19 10:39 RNS Evgen Pharma -4.29% Health £11.8m Posting of Annual Report and AGM Notice
13Jun19 07:00 RNS Evgen Pharma -4.29% Health £11.8m Full Year Results
11Jun19 07:00 RNS Evgen Pharma -4.29% Health £11.8m Notification of Preliminary Results
22May19 13:32 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
21May19 07:00 RNS Evgen Pharma -4.29% Health £11.8m Share Option Exercise and Issue of Equity
09May19 17:49 RNS Amati AIM VCT 0.00% Various Various Holding(s) in Company
09May19 10:11 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
08May19 11:29 RNS Evgen Pharma -4.29% Health £11.8m Result of GM and Completion of Placing
24Apr19 11:37 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
24Apr19 11:33 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
23Apr19 10:30 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
18Apr19 17:30 RNS Evgen Pharma -4.29% Health £11.8m Posting of Circular and Timing of General Meeting
17Apr19 13:00 RNS Evgen Pharma -4.29% Health £11.8m Placing and Notice of General Meeting
02Apr19 09:00 RNS-R Evgen Pharma -4.29% Health £11.8m finnCap publishes initiation research
28Mar19 07:00 RNS-R Evgen Pharma -4.29% Health £11.8m Poster presentation of Imperial College data
25Mar19 07:00 RNS Evgen Pharma -4.29% Health £11.8m SFX-01 meets primary endpoints in STEM trial
18Mar19 07:00 RNS Evgen Pharma -4.29% Health £11.8m Update on SFX-01 trial read-out dates
05Mar19 07:00 RNS Evgen Pharma -4.29% Health £11.8m SFX-01 data published in peer reviewed journal
06Feb19 15:30 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
05Feb19 07:00 RNS Evgen Pharma -4.29% Health £11.8m Clinical trial update confirms read-outs on track
30Jan19 17:28 RNS Evgen Pharma -4.29% Health £11.8m Grant of Options
23Jan19 07:00 RNS-R Evgen Pharma -4.29% Health £11.8m SFX-01 featured in Nature Reviews Drug Discovery
22Jan19 07:00 RNS Evgen Pharma -4.29% Health £11.8m Change of Adviser
19Dec18 18:02 RNS Evgen Pharma -4.29% Health £11.8m Share option exercise and issue of equity
12Dec18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Interim Results
10Dec18 15:00 RNS Evgen Pharma -4.29% Health £11.8m Nominated Adviser Status
04Dec18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Poster Presentation of SFX-01 and Trial Update
03Dec18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Notification of Half Year Results
19Nov18 07:00 RNS-R Evgen Pharma -4.29% Health £11.8m Investor Presentation in Manchester
08Nov18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Directorate Changes
23Oct18 09:57 RNS Evgen Pharma -4.29% Health £11.8m Holding(s) in Company
18Oct18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Placing
18Sep18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Investor Symposium
11Sep18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Notice of Investor Symposium
26Jul18 15:22 RNS Evgen Pharma -4.29% Health £11.8m Result of AGM
26Jul18 07:00 RNS Evgen Pharma -4.29% Health £11.8m AGM Statement
25Jul18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Final Patient Recruited in STEM Phase IIa Trial
10Jul18 11:00 RNS Evgen Pharma -4.29% Health £11.8m Grant of share options, issue of equity and TVR
29Jun18 10:45 EQS Evgen Pharma -4.29% Health £11.8m Hardman & Co Research: Evgen Pharma (EVG): 2018, a pivotal year
21Jun18 12:30 RNS Evgen Pharma -4.29% Health £11.8m Posting of Annual Report and AGM Notice
13Jun18 14:15 EQS Evgen Pharma -4.29% Health £11.8m Hardman & Co Research: Evgen Pharma (EVG): Encouraging interim data from the STEM trial
13Jun18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Full Year Results
11Jun18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Interim Update on STEM Trial
30May18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Notification of Preliminary Results
02May18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Grant of further European patent
24Apr18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Presentation at World Orphan Drug Congress USA
20Mar18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Research Collaboration with Imperial College
05Mar18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Update on Novel Sulforaphane Analogues
15Jan18 07:00 RNS Evgen Pharma -4.29% Health £11.8m Poster Presentation of SFX-01 Mechanistic Data
10Jan18 16:31 RNS Evgen Pharma -4.29% Health £11.8m Notification of Major Interest in Shares
05Jan18 09:49 RNS Evgen Pharma -4.29% Health £11.8m Notification of Major Interest in Shares
05Jan18 09:48 RNS Evgen Pharma -4.29% Health £11.8m Notification of Major Interest in Shares
02Jan18 17:44 RNS Evgen Pharma -4.29% Health £11.8m Total Voting Rights
28Dec17 11:49 RNS Evgen Pharma -4.29% Health £11.8m Result of General Meeting
22Dec17 10:10 RNS Evgen Pharma -4.29% Health £11.8m Grant of Options
13Dec17 07:00 RNS Evgen Pharma -4.29% Health £11.8m Collaboration with King's College London
08Dec17 07:15 RNS Evgen Pharma -4.29% Health £11.8m Placing and Notice of General Meeting
08Dec17 07:00 RNS Evgen Pharma -4.29% Health £11.8m Interim Results
04Oct17 07:00 RNS Evgen Pharma -4.29% Health £11.8m First European Patent Grant
31Aug17 07:00 RNS Evgen Pharma -4.29% Health £11.8m Issue of Equity and Total Voting Rights
27Jul17 07:00 RNS Evgen Pharma -4.29% Health £11.8m Result of AGM
26Jul17 07:00 RNS Evgen Pharma -4.29% Health £11.8m AGM Statement
11Jul17 12:30 RNS Evgen Pharma -4.29% Health £11.8m Charity-funded Study of SFX-01 in TNBC
Date / Time Source Company % Chg
07Jul20 11:13 RNS Evgen Pharma -4.29%
Share option exercise and issue of equity
06Jul20 07:00 RNS Evgen Pharma -4.29%
Share option exercise and issue of equity
23Jun20 11:44 RNS Evgen Pharma -4.29%
Holding(s) in Company
23Jun20 11:38 RNS Evgen Pharma -4.29%
Holding(s) in Company
19Jun20 07:00 RNS Evgen Pharma -4.29%
Notice of AGM
17Jun20 09:38 RNS Evgen Pharma -4.29%
Holding(s) in Company
17Jun20 09:37 RNS Evgen Pharma -4.29%
Holding(s) in Company
17Jun20 07:00 RNS Evgen Pharma -4.29%
SFX-01 to be evaluated in COVID-19 trial
15Jun20 17:05 RNS Evgen Pharma -4.29%
Holding(s) in Company
15Jun20 07:00 RNS Evgen Pharma -4.29%
Final Results
08Jun20 07:00 RNS-R Evgen Pharma -4.29%
Paper on SFX-01 in ER positive breast cancer
05Jun20 07:00 RNS Evgen Pharma -4.29%
Notice of Results
15May20 12:30 RNS Evgen Pharma -4.29%
Statement Re: Share Price Movement
30Apr20 07:00 RNS Evgen Pharma -4.29%
Directorate Change
20Feb20 09:27 RNS Evgen Pharma -4.29%
Holding(s) in Company
13Feb20 07:00 RNS Evgen Pharma -4.29%
University of Rochester Collaboration
06Feb20 07:00 RNS Evgen Pharma -4.29%
University of Manchester collaboration discovery
20Jan20 15:39 RNS Evgen Pharma -4.29%
Holding(s) in Company
17Jan20 15:32 RNS Amati AIM VCT 0.00%
Holding(s) in Company
08Jan20 09:52 RNS Amati AIM VCT 0.00%
Holding(s) in Company
17Dec19 07:01 RNS-R Evgen Pharma -4.29%
Investor presentation
17Dec19 07:00 RNS Evgen Pharma -4.29%
Half-year Report
05Dec19 07:00 RNS Evgen Pharma -4.29%
MOU with The University of Dundee
04Dec19 15:11 RNS Evgen Pharma -4.29%
Notice of Results
14Nov19 11:59 RNS Evgen Pharma -4.29%
Holding(s) in Company
11Nov19 12:11 RNS Evgen Pharma -4.29%
SAS study clarification
11Nov19 07:00 RNS Evgen Pharma -4.29%
SFX-01 results in SAS study
30Sep19 07:00 RNS Evgen Pharma -4.29%
ESMO presentation of Phase II STEM clinical data
23Sep19 07:00 RNS Evgen Pharma -4.29%
Update on extended-use phase of STEM trial
05Sep19 07:00 RNS Evgen Pharma -4.29%
Agreement for supply of SFX-01 for autism trial
28Aug19 07:00 RNS Evgen Pharma -4.29%
Update on SAS study
07Aug19 07:00 RNS Evgen Pharma -4.29%
Grant of further European patent
05Aug19 07:00 RNS-R Evgen Pharma -4.29%
Research collaboration
25Jul19 13:00 RNS Evgen Pharma -4.29%
Grant of Options
18Jul19 15:47 RNS Evgen Pharma -4.29%
Result of AGM
18Jul19 07:00 RNS Evgen Pharma -4.29%
AGM Statement
24Jun19 07:00 RNS-R Evgen Pharma -4.29%
SFX-01 featured in SAH review paper
19Jun19 10:39 RNS Evgen Pharma -4.29%
Posting of Annual Report and AGM Notice
13Jun19 07:00 RNS Evgen Pharma -4.29%
Full Year Results
11Jun19 07:00 RNS Evgen Pharma -4.29%
Notification of Preliminary Results
22May19 13:32 RNS Evgen Pharma -4.29%
Holding(s) in Company
21May19 07:00 RNS Evgen Pharma -4.29%
Share Option Exercise and Issue of Equity
09May19 17:49 RNS Amati AIM VCT 0.00%
Holding(s) in Company
09May19 10:11 RNS Evgen Pharma -4.29%
Holding(s) in Company
08May19 11:29 RNS Evgen Pharma -4.29%
Result of GM and Completion of Placing
24Apr19 11:37 RNS Evgen Pharma -4.29%
Holding(s) in Company
24Apr19 11:33 RNS Evgen Pharma -4.29%
Holding(s) in Company
23Apr19 10:30 RNS Evgen Pharma -4.29%
Holding(s) in Company
18Apr19 17:30 RNS Evgen Pharma -4.29%
Posting of Circular and Timing of General Meeting
17Apr19 13:00 RNS Evgen Pharma -4.29%
Placing and Notice of General Meeting
02Apr19 09:00 RNS-R Evgen Pharma -4.29%
finnCap publishes initiation research
28Mar19 07:00 RNS-R Evgen Pharma -4.29%
Poster presentation of Imperial College data
25Mar19 07:00 RNS Evgen Pharma -4.29%
SFX-01 meets primary endpoints in STEM trial
18Mar19 07:00 RNS Evgen Pharma -4.29%
Update on SFX-01 trial read-out dates
05Mar19 07:00 RNS Evgen Pharma -4.29%
SFX-01 data published in peer reviewed journal
06Feb19 15:30 RNS Evgen Pharma -4.29%
Holding(s) in Company
05Feb19 07:00 RNS Evgen Pharma -4.29%
Clinical trial update confirms read-outs on track
30Jan19 17:28 RNS Evgen Pharma -4.29%
Grant of Options
23Jan19 07:00 RNS-R Evgen Pharma -4.29%
SFX-01 featured in Nature Reviews Drug Discovery
22Jan19 07:00 RNS Evgen Pharma -4.29%
Change of Adviser
19Dec18 18:02 RNS Evgen Pharma -4.29%
Share option exercise and issue of equity
12Dec18 07:00 RNS Evgen Pharma -4.29%
Interim Results
10Dec18 15:00 RNS Evgen Pharma -4.29%
Nominated Adviser Status
04Dec18 07:00 RNS Evgen Pharma -4.29%
Poster Presentation of SFX-01 and Trial Update
03Dec18 07:00 RNS Evgen Pharma -4.29%
Notification of Half Year Results
19Nov18 07:00 RNS-R Evgen Pharma -4.29%
Investor Presentation in Manchester
08Nov18 07:00 RNS Evgen Pharma -4.29%
Directorate Changes
23Oct18 09:57 RNS Evgen Pharma -4.29%
Holding(s) in Company
18Oct18 07:00 RNS Evgen Pharma -4.29%
Placing
18Sep18 07:00 RNS Evgen Pharma -4.29%
Investor Symposium
11Sep18 07:00 RNS Evgen Pharma -4.29%
Notice of Investor Symposium
26Jul18 15:22 RNS Evgen Pharma -4.29%
Result of AGM
26Jul18 07:00 RNS Evgen Pharma -4.29%
AGM Statement
25Jul18 07:00 RNS Evgen Pharma -4.29%
Final Patient Recruited in STEM Phase IIa Trial
10Jul18 11:00 RNS Evgen Pharma -4.29%
Grant of share options, issue of equity and TVR
29Jun18 10:45 EQS Evgen Pharma -4.29%
Hardman & Co Research: Evgen Pharma (EVG): 2018, a pivotal year
21Jun18 12:30 RNS Evgen Pharma -4.29%
Posting of Annual Report and AGM Notice
13Jun18 14:15 EQS Evgen Pharma -4.29%
Hardman & Co Research: Evgen Pharma (EVG): Encouraging interim data from the STEM trial
13Jun18 07:00 RNS Evgen Pharma -4.29%
Full Year Results
11Jun18 07:00 RNS Evgen Pharma -4.29%
Interim Update on STEM Trial
30May18 07:00 RNS Evgen Pharma -4.29%
Notification of Preliminary Results
02May18 07:00 RNS Evgen Pharma -4.29%
Grant of further European patent
24Apr18 07:00 RNS Evgen Pharma -4.29%
Presentation at World Orphan Drug Congress USA
20Mar18 07:00 RNS Evgen Pharma -4.29%
Research Collaboration with Imperial College
05Mar18 07:00 RNS Evgen Pharma -4.29%
Update on Novel Sulforaphane Analogues
15Jan18 07:00 RNS Evgen Pharma -4.29%
Poster Presentation of SFX-01 Mechanistic Data
10Jan18 16:31 RNS Evgen Pharma -4.29%
Notification of Major Interest in Shares
05Jan18 09:49 RNS Evgen Pharma -4.29%
Notification of Major Interest in Shares
05Jan18 09:48 RNS Evgen Pharma -4.29%
Notification of Major Interest in Shares
02Jan18 17:44 RNS Evgen Pharma -4.29%
Total Voting Rights
28Dec17 11:49 RNS Evgen Pharma -4.29%
Result of General Meeting
22Dec17 10:10 RNS Evgen Pharma -4.29%
Grant of Options
13Dec17 07:00 RNS Evgen Pharma -4.29%
Collaboration with King's College London
08Dec17 07:15 RNS Evgen Pharma -4.29%
Placing and Notice of General Meeting
08Dec17 07:00 RNS Evgen Pharma -4.29%
Interim Results
04Oct17 07:00 RNS Evgen Pharma -4.29%
First European Patent Grant
31Aug17 07:00 RNS Evgen Pharma -4.29%
Issue of Equity and Total Voting Rights
27Jul17 07:00 RNS Evgen Pharma -4.29%
Result of AGM
26Jul17 07:00 RNS Evgen Pharma -4.29%
AGM Statement
11Jul17 12:30 RNS Evgen Pharma -4.29%
Charity-funded Study of SFX-01 in TNBC
Date / Time Company % Chg
07Jul20 11:13 Evgen Pharma -4.29%
Share option exercise and issue of equity
06Jul20 07:00 Evgen Pharma -4.29%
Share option exercise and issue of equity
23Jun20 11:44 Evgen Pharma -4.29%
Holding(s) in Company
23Jun20 11:38 Evgen Pharma -4.29%
Holding(s) in Company
19Jun20 07:00 Evgen Pharma -4.29%
Notice of AGM
17Jun20 09:38 Evgen Pharma -4.29%
Holding(s) in Company
17Jun20 09:37 Evgen Pharma -4.29%
Holding(s) in Company
17Jun20 07:00 Evgen Pharma -4.29%
SFX-01 to be evaluated in COVID-19 trial
15Jun20 17:05 Evgen Pharma -4.29%
Holding(s) in Company
15Jun20 07:00 Evgen Pharma -4.29%
Final Results
08Jun20 07:00 Evgen Pharma -4.29%
Paper on SFX-01 in ER positive breast cancer
05Jun20 07:00 Evgen Pharma -4.29%
Notice of Results
15May20 12:30 Evgen Pharma -4.29%
Statement Re: Share Price Movement
30Apr20 07:00 Evgen Pharma -4.29%
Directorate Change
20Feb20 09:27 Evgen Pharma -4.29%
Holding(s) in Company
13Feb20 07:00 Evgen Pharma -4.29%
University of Rochester Collaboration
06Feb20 07:00 Evgen Pharma -4.29%
University of Manchester collaboration discovery
20Jan20 15:39 Evgen Pharma -4.29%
Holding(s) in Company
17Jan20 15:32 AMAT LSE,EVG LSE 0.00%
Holding(s) in Company
08Jan20 09:52 AMAT LSE,EVG LSE 0.00%
Holding(s) in Company
17Dec19 07:01 Evgen Pharma -4.29%
Investor presentation
17Dec19 07:00 Evgen Pharma -4.29%
Half-year Report
05Dec19 07:00 Evgen Pharma -4.29%
MOU with The University of Dundee
04Dec19 15:11 Evgen Pharma -4.29%
Notice of Results
14Nov19 11:59 Evgen Pharma -4.29%
Holding(s) in Company
11Nov19 12:11 Evgen Pharma -4.29%
SAS study clarification
11Nov19 07:00 Evgen Pharma -4.29%
SFX-01 results in SAS study
30Sep19 07:00 Evgen Pharma -4.29%
ESMO presentation of Phase II STEM clinical data
23Sep19 07:00 Evgen Pharma -4.29%
Update on extended-use phase of STEM trial
05Sep19 07:00 Evgen Pharma -4.29%
Agreement for supply of SFX-01 for autism trial
28Aug19 07:00 Evgen Pharma -4.29%
Update on SAS study
07Aug19 07:00 Evgen Pharma -4.29%
Grant of further European patent
05Aug19 07:00 Evgen Pharma -4.29%
Research collaboration
25Jul19 13:00 Evgen Pharma -4.29%
Grant of Options
18Jul19 15:47 Evgen Pharma -4.29%
Result of AGM
18Jul19 07:00 Evgen Pharma -4.29%
AGM Statement
24Jun19 07:00 Evgen Pharma -4.29%
SFX-01 featured in SAH review paper
19Jun19 10:39 Evgen Pharma -4.29%
Posting of Annual Report and AGM Notice
13Jun19 07:00 Evgen Pharma -4.29%
Full Year Results
11Jun19 07:00 Evgen Pharma -4.29%
Notification of Preliminary Results
22May19 13:32 Evgen Pharma -4.29%
Holding(s) in Company
21May19 07:00 Evgen Pharma -4.29%
Share Option Exercise and Issue of Equity
09May19 17:49 AMAT LSE,EVG LSE 0.00%
Holding(s) in Company
09May19 10:11 Evgen Pharma -4.29%
Holding(s) in Company
08May19 11:29 Evgen Pharma -4.29%
Result of GM and Completion of Placing
24Apr19 11:37 Evgen Pharma -4.29%
Holding(s) in Company
24Apr19 11:33 Evgen Pharma -4.29%
Holding(s) in Company
23Apr19 10:30 Evgen Pharma -4.29%
Holding(s) in Company
18Apr19 17:30 Evgen Pharma -4.29%
Posting of Circular and Timing of General Meeting
17Apr19 13:00 Evgen Pharma -4.29%
Placing and Notice of General Meeting
02Apr19 09:00 Evgen Pharma -4.29%
finnCap publishes initiation research
28Mar19 07:00 Evgen Pharma -4.29%
Poster presentation of Imperial College data
25Mar19 07:00 Evgen Pharma -4.29%
SFX-01 meets primary endpoints in STEM trial
18Mar19 07:00 Evgen Pharma -4.29%
Update on SFX-01 trial read-out dates
05Mar19 07:00 Evgen Pharma -4.29%
SFX-01 data published in peer reviewed journal
06Feb19 15:30 Evgen Pharma -4.29%
Holding(s) in Company
05Feb19 07:00 Evgen Pharma -4.29%
Clinical trial update confirms read-outs on track
30Jan19 17:28 Evgen Pharma -4.29%
Grant of Options
23Jan19 07:00 Evgen Pharma -4.29%
SFX-01 featured in Nature Reviews Drug Discovery
22Jan19 07:00 Evgen Pharma -4.29%
Change of Adviser
19Dec18 18:02 Evgen Pharma -4.29%
Share option exercise and issue of equity
12Dec18 07:00 Evgen Pharma -4.29%
Interim Results
10Dec18 15:00 Evgen Pharma -4.29%
Nominated Adviser Status
04Dec18 07:00 Evgen Pharma -4.29%
Poster Presentation of SFX-01 and Trial Update
03Dec18 07:00 Evgen Pharma -4.29%
Notification of Half Year Results
19Nov18 07:00 Evgen Pharma -4.29%
Investor Presentation in Manchester
08Nov18 07:00 Evgen Pharma -4.29%
Directorate Changes
23Oct18 09:57 Evgen Pharma -4.29%
Holding(s) in Company
18Oct18 07:00 Evgen Pharma -4.29%
Placing
18Sep18 07:00 Evgen Pharma -4.29%
Investor Symposium
11Sep18 07:00 Evgen Pharma -4.29%
Notice of Investor Symposium
26Jul18 15:22 Evgen Pharma -4.29%
Result of AGM
26Jul18 07:00 Evgen Pharma -4.29%
AGM Statement
25Jul18 07:00 Evgen Pharma -4.29%
Final Patient Recruited in STEM Phase IIa Trial
10Jul18 11:00 Evgen Pharma -4.29%
Grant of share options, issue of equity and TVR
29Jun18 10:45 Evgen Pharma -4.29%
Hardman & Co Research: Evgen Pharma (EVG): 2018, a pivotal year
21Jun18 12:30 Evgen Pharma -4.29%
Posting of Annual Report and AGM Notice
13Jun18 14:15 Evgen Pharma -4.29%
Hardman & Co Research: Evgen Pharma (EVG): Encouraging interim data from the STEM trial
13Jun18 07:00 Evgen Pharma -4.29%
Full Year Results
11Jun18 07:00 Evgen Pharma -4.29%
Interim Update on STEM Trial
30May18 07:00 Evgen Pharma -4.29%
Notification of Preliminary Results
02May18 07:00 Evgen Pharma -4.29%
Grant of further European patent
24Apr18 07:00 Evgen Pharma -4.29%
Presentation at World Orphan Drug Congress USA
20Mar18 07:00 Evgen Pharma -4.29%
Research Collaboration with Imperial College
05Mar18 07:00 Evgen Pharma -4.29%
Update on Novel Sulforaphane Analogues
15Jan18 07:00 Evgen Pharma -4.29%
Poster Presentation of SFX-01 Mechanistic Data
10Jan18 16:31 Evgen Pharma -4.29%
Notification of Major Interest in Shares
05Jan18 09:49 Evgen Pharma -4.29%
Notification of Major Interest in Shares
05Jan18 09:48 Evgen Pharma -4.29%
Notification of Major Interest in Shares
02Jan18 17:44 Evgen Pharma -4.29%
Total Voting Rights
28Dec17 11:49 Evgen Pharma -4.29%
Result of General Meeting
22Dec17 10:10 Evgen Pharma -4.29%
Grant of Options
13Dec17 07:00 Evgen Pharma -4.29%
Collaboration with King's College London
08Dec17 07:15 Evgen Pharma -4.29%
Placing and Notice of General Meeting
08Dec17 07:00 Evgen Pharma -4.29%
Interim Results
04Oct17 07:00 Evgen Pharma -4.29%
First European Patent Grant
31Aug17 07:00 Evgen Pharma -4.29%
Issue of Equity and Total Voting Rights
27Jul17 07:00 Evgen Pharma -4.29%
Result of AGM
26Jul17 07:00 Evgen Pharma -4.29%
AGM Statement
11Jul17 12:30 Evgen Pharma -4.29%
Charity-funded Study of SFX-01 in TNBC